ChemoCentryx, Inc. — Operating Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/037aa1df-1cc4-4c05-9ba1-7c4d8afb88e5/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-129.9M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-002561 |
| FY 2020 | $-55.2M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-009883 |
| FY 2019 | $-58.3M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-009787 |
| FY 2018 | $-40.3M | 2018-01-01 – 2018-12-31 | evidence 0001193125-19-070954 |
| FY 2017 | $16.5M | 2017-01-01 – 2017-12-31 | evidence 0001193125-18-079260 |
| FY 2016 | $-40.7M | 2016-01-01 – 2016-12-31 | evidence 0001193125-17-082093 |
| FY 2015 | $-47.7M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-503608 |
| FY 2014 | $-47.4M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-090602 |
| FY 2013 | $-39.1M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-099600 |
| FY 2012 | $-39.6M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-107109 |
| FY 2011 | $-4.3M | 2011-01-01 – 2011-12-31 | evidence 0001193125-13-107109 |
| FY 2010 | $-6.0M | 2010-01-01 – 2010-12-31 | evidence 0001193125-13-107109 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).